Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Current Medical Science|March 11, 2025
Efficacy and Safety of Third-Generation EGFR-TKIs Combined with Radiotherapy for Advanced NSCLC with Typical EGFR Mutations: A Retrospective StudyWen-Xuan Zhang, Hui-Chan Xue, Ye Zhao, et al.Journal of Cancer Research and Clinical Oncology|June 10, 2008
Differential IL-4/Stat6 activities correlate with differential expression of regulatory genes SOCS-1, SHP-1, and PP2A in colon cancer cellsQin Yuan, Pin Dong Li, Ben Hui Li, et al.Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban|April 9, 2014
Synthesis and characterization of surface-modified Fe3O4 super-paramagnetic nanoparticlesZhan-Jie Zhang, Jia Ma, Shuang-Bing Xu, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 26, 2009
Defective interleukin-4/Stat6 activity correlates with increased constitutive expression of negative regulators SOCS-3, SOCS-7, and CISH in colon cancer cellsXiao Hong Liu, Shuang Bing Xu, Jia Yuan, et al.Cellular Signalling|November 24, 2011
Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivoBen Hui Li, Shuang Bing Xu, Feng Li, et al.Journal of Cancer Research and Clinical Oncology|June 25, 2009
DNA methylation regulates constitutive expression of Stat6 regulatory genes SOCS-1 and SHP-1 in colon cancer cellsShuang Bing Xu, Xiao Hong Liu, Ben Hui Li, et al.Translational Oncology|March 15, 2022
Prediction of response and adverse drug reaction of pemetrexed plus platinum-based chemotherapy in lung adenocarcinoma by serum metabolomic profilingWei-Jing Gong, Peng Cao, Qi-Lin Zhang, et al.Cytokine|March 18, 2008
IL-4-induced Stat6 activities affect apoptosis and gene expression in breast cancer cellsWen Jie Zhang, Ben Hui Li, Xian Zi Yang, et al.Journal of Cancer|September 14, 2020
Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective StudyQi-Wen Li, Bo Qiu, Wen-Hua Liang, et al.Pageof 1